LNTH FY 2019 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

FY 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$347M+1.2% YoY

Gross Profit

$175M50.3% margin

Operating Income

$52M14.9% margin

Net Income

$32M9.1% margin

EPS (Diluted)

$0.79

Cash Flow

Operating Cash Flow

$80M

Free Cash Flow

$58M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$406M

Total Liabilities

$291M

Stockholders' Equity

$115M

Cash & Equivalents

$93M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$347M	$343M	+1.2%
Gross Profit	$175M	$175M	-0.0%
Operating Income	$52M	$64M	-19.9%
Net Income	$32M	$41M	-21.8%